Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.10% · OPTIONAL
· Services-Commercial Physical & Biological Research
RESEARCH SNAPSHOTCHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s latest supported as-filed period reports revenue of $1.0B. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.10% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 17.90% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -2.72% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 34.49% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 11.94% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.97% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 23.9%; Inventory / revenue moved 740 bp higher.
2 evidence-backed componentsDebt changed +5471.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Each point keeps the date investors could first observe it and its accession.
CRL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001100682-26-000140SEC ↗4Aug 20, 2026Period Aug 19, 20260001100682-26-000138SEC ↗4Aug 20, 2026Period Aug 19, 20260001100682-26-000136SEC ↗4Aug 20, 2026Period Aug 18, 20260001100682-26-000134SEC ↗4Aug 13, 2026Period Aug 11, 20260001100682-26-000132SEC ↗4Aug 13, 2026Period Aug 11, 20260001100682-26-000130SEC ↗4Aug 11, 2026Period Aug 10, 20260001100682-26-000128SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 25, 2026Filed Aug 27, 2026 | FOSTER JAMES CDirector | Option ExerciseDirect | 21,132 | $194 | $4.1M | Form 4 ↗ |
| Aug 25, 2026Filed Aug 27, 2026 | FOSTER JAMES CDirector | Option ExerciseDirect | 12,429 | $208 | $2.6M | Form 4 ↗ |
| Aug 25, 2026Filed Aug 27, 2026 | FOSTER JAMES CDirector | Open Market SaleDirect | 33,561 | $300 | $10.1M | Form 4 ↗ |
| Aug 25, 2026Filed Aug 27, 2026 | FOSTER JAMES CDirector | Option ExerciseDirect | 21,132 | $0 | $0 | Form 4 ↗ |
| Aug 25, 2026Filed Aug 27, 2026 | FOSTER JAMES C |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating margin changed +224 basis points from the comparable as-filed period.
Inventory / revenue changed +740 basis points from the comparable as-filed period.
Operating income changed +19.7% from the comparable as-filed period.
Inventory changed +23.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed -102.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Selling, general & administrative changed +19.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-27. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001100682-26-000126| Option ExerciseDirect |
| 12,429 |
| $0 |
| $0 |
| Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Girshick BirgitChief Executive Officer | GiftDirect | 528 | $0 | $0 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Option ExerciseDirect | 2,039 | $194 | $395,811 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Open Market SaleDirect | 2,039 | $294 | $599,711 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Option ExerciseDirect | 2,039 | $0 | $0 | Form 4 ↗ |
| Aug 18, 2026Filed Aug 20, 2026 | Andrews Nancy CDirector | Option ExerciseDirect | 573 | $164 | $94,144 | Form 4 ↗ |
| Aug 18, 2026Filed Aug 20, 2026 | Andrews Nancy CDirector | Open Market SaleDirect | 573 | $285 | $163,443 | Form 4 ↗ |
| Aug 18, 2026Filed Aug 20, 2026 | Andrews Nancy CDirector | Option ExerciseDirect | 573 | $0 | $0 | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Girshick BirgitChief Executive Officer | Option ExerciseDirect | 6,500 | $180 | $1.2M | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Girshick BirgitChief Executive Officer | Open Market SaleDirect | 6,500 | $280 | $1.8M | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Girshick BirgitChief Executive Officer | Option ExerciseDirect | 6,500 | $0 | $0 | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Option ExerciseDirect | 3,714 | $180 | $667,257 | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Open Market SaleDirect | 3,714 | $280 | $1.0M | Form 4 ↗ |
| Aug 11, 2026Filed Aug 13, 2026 | Parisotto Shannon MCEVP, Disc & Safety Assessment | Option ExerciseDirect | 3,714 | $0 | $0 | Form 4 ↗ |
| Aug 10, 2026Filed Aug 11, 2026 | LaPlume Joseph WEVP, Corp Strategy & Develop | GiftDirect | 257 | $0 | $0 | Form 4 ↗ |
| Aug 10, 2026Filed Aug 11, 2026 | FOSTER JAMES CDirector | Option ExerciseDirect | 28,733 | $180 | $5.2M | Form 4 ↗ |